LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years

S. Raimundo (Vila Real, Portugal), A. Loureiro (Vila Real, Portugal), F. Vieira (Trofa, Portugal), A. Fernandes (Vila Real, Portugal)

Source: International Congress 2019 – Biology and prognosis of lung cancer
Session: Biology and prognosis of lung cancer
Session type: Thematic Poster
Number: 3049
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Raimundo (Vila Real, Portugal), A. Loureiro (Vila Real, Portugal), F. Vieira (Trofa, Portugal), A. Fernandes (Vila Real, Portugal). LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years. 3049

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Survival of patients with malignant pleural effusions: a three-year prospective self-experience study
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions
Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Year: 2012


Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Malignant pleural mesothelioma in our material: evaluation by EORTC prognostic scoring system
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Source: International Congress 2016 – Pleural diseases
Year: 2016


Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009


Malignant pleural effusion survival prognostication in an Asian population
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019



Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020

Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion
Source: Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019
Year: 2020



Late Breaking Abstract - Prognostic and therapeutic markers of malignant pleural effusion – The PROMISE study
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017



Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004